high purity, Mv 140,000-220,000

Deacetylated chitin, Poly(D-glucosamine), KiOmedine-CsU D
CAS Number:
MDL number:
Pricing and availability is not currently available.

biological source

white mushroom


high purity

mol wt

Mv 140,000-220,000


Bacterial endotoxins, ≤10 EU/g
Beta-glucan, ≤5 % (w/w)
Chitosan, ≥93 % (w/w)
Proteins, ≤1 % (w/w)


5-200 mPa.s (1% solution in 1% HAc)

storage temp.




InChI key


Looking for similar products? Visit Product Comparison Guide

General description

KiOmedine-CsU® is an ultra-pure chitosan of non-animal origin, produced from white mushrooms (Agaricus bisporus), in accordance with cGMP.
The crystalline structure is in the alpha form. The linkage between glucosamine units is beta(1,4).


Forms gels with multivalent anions. Gives clear solutions that dry to strong, clear films.
Ideal for wound healing and hemostasis; biosurgery and ophthalmology; scaffold and cell therapy; and drug delivery and vaccines

Features and Benefits

Biocompatible, antibacterial and environmentally friendly polyelectrolyte with a variety of applications including water treatment, chromatography, additives for cosmetics, textile treatment for antimicrobial activity, novel fibers for textiles, photographic papers, biodegradable films, biomedical devices, and microcapsule implants for controlled release in drug delivery.

Physical properties

Degree of acetylation: ≤40 mol. %

Legal Information

Product of KitoZyme
KiOmedine is a registered trademark of KitoZyme, S.A.


NONH for all modes of transport

WGK Germany


Certificate of Analysis
Certificate of Origin
Gregory H Bird et al.
The Journal of clinical investigation, 124(5), 2113-2124 (2014-04-20)
Respiratory syncytial virus (RSV) infection accounts for approximately 64 million cases of respiratory disease and 200,000 deaths worldwide each year, yet no broadly effective prophylactic or treatment regimen is available. RSV deploys paired, self-associating, heptad repeat domains of its fusion...
Abdelkrim El Kadib et al.
Journal of nanoscience and nanotechnology, 14(1), 308-331 (2014-04-16)
Polysaccharides are a new class of pervasive biopolymers that display many advantages including wide availability, sustainability, inherent inclusion of chemical functionality, biocompatibility and biodegradability. Current efforts are focused on the catalytic transformation of these macromolecules into fuels and platform chemicals....
Electrochemical biosensor applications of polysaccharides chitin and chitosan.
Wipa Suginta et al.
Chemical reviews, 113(7), 5458-5479 (2013-04-06)
William D Stanish et al.
The Journal of bone and joint surgery. American volume, 95(18), 1640-1650 (2013-09-21)
Microfracture, the standard of care, is recognized to be an incomplete solution for cartilage damage. BST-CarGel, a chitosan-based medical device, is mixed with autologous whole blood and is applied to a microfractured cartilage lesion in which it physically stabilizes the...
Stephanie Supper et al.
Expert opinion on drug delivery, 11(2), 249-267 (2013-12-07)
Thermogelling chitosan (CS)/glycerophosphate (GP) solutions have been reported as a new type of parenteral in situ forming depot system. These free-flowing solutions at ambient temperature turn into semi-solid hydrogels after parenteral administration. Formulation parameters such as CS physico-chemical characteristics, CS/gelling...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.